5Pauwels O, Gozy M, Van Houtte P, et al. Cross resistance and collateral sensitivity between cytotoxic drugs and radiation in two human bladder cell lines. Radiother Oncol, 1996, 39 (1):81-86.
6Hill BT, Deuchars K, Hosking LK, et al. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro. J Nail Cancer lnst, 1990, 82 (7): 607-612.
7McClean S, Hosking LK, Hill BT. Expression of P-glycoprotein-mediated drug resistance in CHO cells surviving a single X-ray dose of 30Gy. Int J Radiat Biol, 1993, 63 (6): 765-773.
8Piwnica-Worms D, Chiw ML, Budding M, et al. Functional imaging of mttltidrug resistance P-glycoprotein with an organotechnetium complex. Cancer Res, 1993, 53: 972-984.
9Higashi I, Wakao H, Nakamura K, et al. Quantitative gallium-67 scanning for predictive value in primary lung carcinoma.J Nucl Med, 1980, 21 (7): 628-632.
10Yarnaji S. Usefulness of ^201T1 SPECT in the evaluation of treatment effect for primary lung cancer. Kaku Igaku, 1995, 32(12): 1333-1340.
6Nosotti M, Santambrogio L, Casparini M, et al. Role of ( 99m ) tc - hexakis- 2 -methoxy -isobutylisonitrile in the diagnosis and staging of lung cancer. Chest,2002,122(4) :1361 - 1364.
